Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

An Italian Multicentre Study Using Different Digital PCR Instruments on BCR-ABL1 Positive Patients at Different Levels of CML Disease

Filomena Daraio, PhD, Emilia Giugliano, Carmen Fava, MD PhD, Roberta Lorenzatti, Dr., Marta Varotto, Dr., Davide Barberio, Dr., Simona Bernardi, PhD, Barbara Izzo, PhD, Santa Errichiello, PhD, Maria Teresa Bochicchio, Claudia Venturi, Dr., Francesco Albano, MD, Giuseppe Saglio, MD PhD, Fabrizio Pane, MD, Giovanni Martinelli, MD, Giorgina Specchia, MD, Domenico Russo, MD, Enrico Marco Gottardi, Dr.

Blood (2017) 130 (Supplement 1): 4176.

https://doi.org/10.1182/blood.V130.Suppl_1.4176.4176

Published: 2017

Journal Articles

Standardization of Two Dpcr Platforms for Detection of BCR/ABL1 - Minimal Residual Disease (MRD) in Ph+ Chronic Myeloid Leukemia (CML)

Carmen Fava, MD PhD, Simona Bernardi, PhD, Enrico Marco Gottardi, Dr., Filomena Daraio, PhD, Emilia Giugliano, Roberta Lorenzatti, Dr., Marta Varotto, Dr., Davide Barberio, Dr., Laura Galeotti, Francesco Ceccherini, Francesco Cordoni, Giovanna Rege-Carmbrin, Giuseppe Saglio, MD PhD, Domenico Russo, MD

Blood (2017) 130 (Supplement 1): 2867.

https://doi.org/10.1182/blood.V130.Suppl_1.2867.2867

Published: 2017

Journal Articles

A New Sensitive and Fast Molecular Analysis Method for the Identification of 30 Different Markers in Acute Myeloid and Lymphoid Leukemias at Diagnosis Time

Emilia Giugliano, Roberta Lorenzatti, Dr., Enrico Marco Gottardi, Dr., Chiara Sammartino, Dr., Roberta Toja, Francesca Crasto, Dr, Alessandro Volpengo, Dr, Cristina Fantino, Dr, Filomena Daraio, PhD, Anna Serra, Dr, Francesca Carnuccio, Dr, Giuseppe Saglio, MD PhD, Angelo Guerrasio, MD

Blood (2017) 130 (Supplement 1): 5097.

https://doi.org/10.1182/blood.V130.Suppl_1.5097.5097

Published: 2017

Journal Articles

One-Step Quantitative Molecular Approach for Detection of BCR/ABL1 Rearrangement and for Monitoring of Minimal Residual Disease in CML Patients: An Inter Laboratory Study

Filomena Daraio, PhD, Maria Teresa Bochicchio, Dr., Barbara Izzo, PhD Prof., Claudia Venturi, Dr., Santa Errichiello, PhD, Francesca Crasto, Dr., Giovanna Rege-Cambrin, MD, Roberta Lorenzatti, Dr., Carmen Fava, MD, Fausto Castagnetti, MD, Fabrizio Pane, MD Prof., Giovanni Martinelli, MD Prof., Giuseppe Saglio, MD Prof., Enrico Marco Gottardi, Dr.

Blood (2016) 128 (22): 5423.

https://doi.org/10.1182/blood.V128.22.5423.5423

Published: 2016

Journal Articles

A Sensitive Replicate RQ-PCR of BCR ABL Transcripts Suggests That A Large Portion of Long Term Post Allogeneic SCT CML Patients Are in Deep MR and May Therefore Be Cured From Their Disease

Maya Koren-Michowitz, Avichai Shimoni, Filomena Daraio, Dr, Francesca Crasto, Dr, Roberta Lorenzatti, Dr, Yulia Volchek, Ninette Amariglio, Enrico Gottardi, MD, Giuseppe Saglio, MD, Arnon Nagler, MD

Blood (2012) 120 (21): 1690.

https://doi.org/10.1182/blood.V120.21.1690.1690

Published: 2012

Journal Articles

One Step Quantitative Molecular Approach for Detection of BCR/ABL Translocation and for Monitoring and Follow up of the Minimal Residual Disease in CML Patients Under Tyrosine Kines Inhibitors Treatment

Filomena Daraio, Dr, Davide Barberis, PhD, Francesca Crasto, Dr, Giovanna Rege-Cambrin, Cristina Olivo, PhD, Matteo Renzulli, PhD, Rosy Volpi, PhD, Roberta Lorenzatti, Dr, Carmen Fava, MD, Enrico Gottardi, MD, Giuseppe Saglio, MD

Blood (2012) 120 (21): 4435.

https://doi.org/10.1182/blood.V120.21.4435.4435

Published: 2012

NARROW

An Italian Multicentre Study Using Different Digital PCR Instruments on BCR-ABL1 Positive Patients at Different Levels of CML Disease

Standardization of Two Dpcr Platforms for Detection of BCR/ABL1 - Minimal Residual Disease (MRD) in Ph+ Chronic Myeloid Leukemia (CML)

A New Sensitive and Fast Molecular Analysis Method for the Identification of 30 Different Markers in Acute Myeloid and Lymphoid Leukemias at Diagnosis Time

One-Step Quantitative Molecular Approach for Detection of BCR/ABL1 Rearrangement and for Monitoring of Minimal Residual Disease in CML Patients: An Inter Laboratory Study

A Sensitive Replicate RQ-PCR of BCR ABL Transcripts Suggests That A Large Portion of Long Term Post Allogeneic SCT CML Patients Are in Deep MR and May Therefore Be Cured From Their Disease

One Step Quantitative Molecular Approach for Detection of BCR/ABL Translocation and for Monitoring and Follow up of the Minimal Residual Disease in CML Patients Under Tyrosine Kines Inhibitors Treatment

Email alerts

ASH Publications

American Society of Hematology

An Italian Multicentre Study Using Different Digital PCR Instruments on BCR-ABL1 Positive Patients at Different Levels of CML Disease

Standardization of Two Dpcr Platforms for Detection of BCR/ABL1 - Minimal Residual Disease (MRD) in Ph+ Chronic Myeloid Leukemia (CML)

A New Sensitive and Fast Molecular Analysis Method for the Identification of 30 Different Markers in Acute Myeloid and Lymphoid Leukemias at Diagnosis Time

One-Step Quantitative Molecular Approach for Detection of BCR/ABL1 Rearrangement and for Monitoring of Minimal Residual Disease in CML Patients: An Inter Laboratory Study

A Sensitive Replicate RQ-PCR of BCR ABL Transcripts Suggests That A Large Portion of Long Term Post Allogeneic SCT CML Patients Are in Deep MR and May Therefore Be Cured From Their Disease

One Step Quantitative Molecular Approach for Detection of BCR/ABL Translocation and for Monitoring and Follow up of the Minimal Residual Disease in CML Patients Under Tyrosine Kines Inhibitors Treatment

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only